aspsirna0426 details

Purple = Wild vs mutant target sequence along with mutation information
Brown= Wild vs ASP-siRNA description along with positional differnece between two
Light pink= ASP siRNA efficacy for mutant vs wild allele
Green= Wild siRNA efficacy for Wild vs Mutant allele
siRNA Id:aspsirna0426
siRNA Name: siG356D_A9_5+
Gene:Activin A receptor type I (ACVR1)
Disease:Fibrodysplasia Ossificans Progressiva (FOP)
Wild allele/target (5'->3'): AGAUUUGGGCCUGGCAGUC
Mutant allele/target (5'->3'):CAGAUUUGGACCUGGCAGUC
Target Mutation: c.1067G>A,p.Gly356Asp
Wild siRNA (As strand):UCUAAACCCGGACCGUCAG
ASP-siRNA (As strand):UCUAAACCUGGACCGUCAG
Mismatch position in siRNA: U11C
Mutant allele (5'->3'): CAGAUUUGGACCUGGCAGUC
ASP-siRNA (As strand):UCUAAACCUGGACCGUCAG
ASP-siRNA efficacy for mutant allele:85
Wild allele (5'->3'): AGAUUUGGGCCUGGCAGUC
ASP-siRNA (As strand):UCUAAACCUGGACCGUCAG
ASP-siRNA efficacy for wild allele:48
Percentage discrimination for ASP-siRNA:37
Wild allele (5'->3'): AGAUUUGGGCCUGGCAGUC
Wild siRNA (As strand):UCUAAACCCGGACCGUCAG
Wild sirna efficacy for wild allele:69
Wild allele (5'->3'): AGAUUUGGGCCUGGCAGUC
ASP-siRNA (As strand):UCUAAACCUGGACCGUCAG
Wild sirna efficacy for mutant allele:38
Percentage discrimination for wild siRNA:31
Concentration:20nM
Orientation:Double strand
Mismatch in:siRNA
UniProt ID: Q06900
Target sequence: GCATAGCAGATTTGGGCCTGGCAGTCATG
Genbank Accesion: NM_001105.4
Cell-line: HeLa
Experimental technique used: Dual luciferase reporter assay
Transfection method: Lipofectamine 2000
siRNA expression method: Sigma-aldrich
Post-transfection duration: 24 hours
OMID ID: 135100
KEGG disease ID:H00430
Reference:22130450

.
.
.
.
.
.
.
.
.
.
.

.

.

.